Literature DB >> 15542424

A new key in breast cancer metastasis.

Jeffrey L Benovic1, Adriano Marchese.   

Abstract

Unlocking the mysteries of cell metastasis, a major cause of cancer mortality, is essential in the development of novel therapies. In this issue of Cancer Cell, Li et al. (2004) identify a link between HER2 and CXCR4, two receptors previously implicated in breast cancer progression and metastasis. HER2 enhances the expression of CXCR4 by stimulating CXCR4 translation and attenuating CXCR4 degradation. Importantly, coexpression of HER2 and CXCR4 occurs in approximately 22% of human breast tumors and correlates with poor survival of breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542424     DOI: 10.1016/j.ccr.2004.10.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  11 in total

1.  The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Authors:  Kristina Subik; Lei Shu; Chengyu Wu; Qianqian Liang; David Hicks; Brendan Boyce; Linda Schiffhauer; Di Chen; Ceshi Chen; Ping Tang; Lianping Xing
Journal:  Bone       Date:  2012-01-11       Impact factor: 4.398

2.  CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4.

Authors:  Thomas Slagsvold; Adriano Marchese; Andreas Brech; Harald Stenmark
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

3.  RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.

Authors:  Eliane Shizuka Nakamura; Keiichi Koizumi; Mitsuo Kobayashi; Yurika Saitoh; Yoshihisa Arita; Takashi Nakayama; Hiroaki Sakurai; Osamu Yoshie; Ikuo Saiki
Journal:  Clin Exp Metastasis       Date:  2006-07-05       Impact factor: 5.150

Review 4.  Regulation of GPCR Trafficking by Ubiquitin.

Authors:  Justine E Kennedy; Adriano Marchese
Journal:  Prog Mol Biol Transl Sci       Date:  2015-03-25       Impact factor: 3.622

Review 5.  Chemokines: key players in cancer progression and metastasis.

Authors:  Rajesh Singh; James W Lillard; Shailesh Singh
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

6.  Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.

Authors:  Kanjoormana Aryan Manu; Muthu K Shanmugam; Peramaiyan Rajendran; Feng Li; Lalitha Ramachandran; Hui Sin Hay; Radhamani Kannaiyan; Shivananju Nanjunda Swamy; Shireen Vali; Shweta Kapoor; Bhargavi Ramesh; Pradeep Bist; Evelyn S Koay; Lina H K Lim; Kwang Seok Ahn; Alan Prem Kumar; Gautam Sethi
Journal:  Mol Cancer       Date:  2011-09-01       Impact factor: 27.401

7.  Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.

Authors:  Kai-Dun Tang; Boris M Holzapfel; Ji Liu; Terence Kin-Wah Lee; Stephanie Ma; Lidija Jovanovic; Jiyuan An; Pamela J Russell; Judith A Clements; Dietmar W Hutmacher; Ming-Tat Ling
Journal:  Oncotarget       Date:  2016-01-19

8.  An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition.

Authors:  Ayesha T Chawla; Agnes D Cororaton; Michael O Idowu; Priyadarshan K Damle; Barbara Szomju; Keith C Ellis; Bhaumik B Patel; Steven R Grossman
Journal:  Oncotarget       Date:  2018-08-21

9.  Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma.

Authors:  Kanjoormana Aryan Manu; Muthu K Shanmugam; Tina H Ong; Aruljothi Subramaniam; Kodappully Sivaraman Siveen; Ekambaram Perumal; Ramar Perumal Samy; Pradeep Bist; Lina H K Lim; Alan Prem Kumar; Kam M Hui; Gautam Sethi
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.

Authors:  Debarati Mukherjee; Heng Lu; Lin Yu; Chunjiang He; Satadru K Lahiri; Tianshu Li; Jihe Zhao
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.